155 related articles for article (PubMed ID: 22973723)
1. [Developing technologies for epigenomic analysis and clinical application of molecular diagnosis].
Yamamoto E; Suzuki H; Maruyama R; Shinomura Y
Rinsho Byori; 2012 Jul; 60(7):637-43. PubMed ID: 22973723
[TBL] [Abstract][Full Text] [Related]
2. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect.
Ando T; Yoshida T; Enomoto S; Asada K; Tatematsu M; Ichinose M; Sugiyama T; Ushijima T
Int J Cancer; 2009 May; 124(10):2367-74. PubMed ID: 19165869
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors.
Kamimae S; Yamamoto E; Yamano HO; Nojima M; Suzuki H; Ashida M; Hatahira T; Sato A; Kimura T; Yoshikawa K; Harada T; Hayashi S; Takamaru H; Maruyama R; Kai M; Nishiwaki M; Sugai T; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
Cancer Prev Res (Phila); 2011 May; 4(5):674-83. PubMed ID: 21543345
[TBL] [Abstract][Full Text] [Related]
6. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
Watanabe Y; Toyota M; Kondo Y; Suzuki H; Imai T; Ohe-Toyota M; Maruyama R; Nojima M; Sasaki Y; Sekido Y; Hiratsuka H; Shinomura Y; Imai K; Itoh F; Tokino T
Clin Cancer Res; 2007 Aug; 13(16):4786-94. PubMed ID: 17699856
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
8. Cancer type-specific epigenetic changes: gastric cancer.
Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae.
Shin CM; Kim N; Park JH; Kang GH; Kim JS; Jung HC; Song IS
J Pathol; 2012 Mar; 226(4):654-65. PubMed ID: 22252584
[TBL] [Abstract][Full Text] [Related]
10. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk.
Maekita T; Nakazawa K; Mihara M; Nakajima T; Yanaoka K; Iguchi M; Arii K; Kaneda A; Tsukamoto T; Tatematsu M; Tamura G; Saito D; Sugimura T; Ichinose M; Ushijima T
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):989-95. PubMed ID: 16467114
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers.
Ushijima T; Hattori N
Clin Cancer Res; 2012 Feb; 18(4):923-9. PubMed ID: 22205689
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk.
Suzuki R; Yamamoto E; Nojima M; Maruyama R; Yamano HO; Yoshikawa K; Kimura T; Harada T; Ashida M; Niinuma T; Sato A; Nosho K; Yamamoto H; Kai M; Sugai T; Imai K; Suzuki H; Shinomura Y
J Gastroenterol; 2014 Jul; 49(7):1135-44. PubMed ID: 23942619
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of RASGRF1 is associated with an epigenetic field defect and increased risk of gastric cancer.
Takamaru H; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Yamano HO; Yoshikawa K; Kimura T; Harada T; Ashida M; Suzuki R; Yamamoto H; Kai M; Tokino T; Sugai T; Imai K; Toyota M; Shinomura Y
Cancer Prev Res (Phila); 2012 Oct; 5(10):1203-12. PubMed ID: 22961779
[TBL] [Abstract][Full Text] [Related]
18. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers.
Nakajima T; Maekita T; Oda I; Gotoda T; Yamamoto S; Umemura S; Ichinose M; Sugimura T; Ushijima T; Saito D
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2317-21. PubMed ID: 17119066
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations in gastric carcinogenesis.
Choi IS; Wu TT
Cell Res; 2005 Apr; 15(4):247-54. PubMed ID: 15857579
[TBL] [Abstract][Full Text] [Related]
20. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
